Literature DB >> 9645546

Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.

P Danos1, B Baumann, H G Bernstein, M Franz, R Stauch, G Northoff, D Krell, P Falkai, B Bogerts.   

Abstract

This study was designed to examine possible anatomical changes of thalamocortical circuits in schizophrenics. Previous immunocytochemical studies have shown that parvalbumin, a calcium-binding protein, occurs in thalamocortical projection neurons, but not in GABAergic interneurons in the anteroventral thalamic nucleus (AN). Using parvalbumin-immunocytochemistry we investigated the densities of thalamocortical projection neurons in the AN of schizophrenic cases (n = 12) and controls (n = 14). The densities of all neurons in the AN were estimated by Nissl-staining. The majority of thalamocortical projection neurons in AN were identified by parvalbumin-immunoreaction. Significantly reduced densities of thalamocortical projection neurons were estimated in the right (P = 0.003) and left AN (P = 0.018) in schizophrenic subjects. The densities of all neurons in right and left AN were also diminished in schizophrenics; however, these decreases did not reach statistical significance. The reductions of parvalbumin-positive thalamocortical projection neurons were not correlated with the length of disease, this finding supporting the neurodevelopmental etiology of structural abnormalities in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645546     DOI: 10.1016/s0925-4927(97)00071-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  26 in total

Review 1.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

2.  Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia.

Authors:  R Y Cho; R O Konecky; C S Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

3.  Spatial working memory and the brainstem cholinergic innervation to the anterior thalamus.

Authors:  Anna S Mitchell; John C Dalrymple-Alford; Michael A Christie
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 4.  Neurochemistry of the Anterior Thalamic Nuclei.

Authors:  Witold Żakowski
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

Review 5.  Neuroanatomical and molecular correlates of cognitive and behavioural outcomes in hypogonadal males.

Authors:  O B Akinola; M O Gabriel
Journal:  Metab Brain Dis       Date:  2017-12-11       Impact factor: 3.584

6.  Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat.

Authors:  Rainer Wolf; Henrik Dobrowolny; Sven Nullmeier; Bernhard Bogerts; Herbert Schwegler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-30       Impact factor: 5.270

7.  Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.

Authors:  Alice Egerton; Lee Reid; Clare E McKerchar; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

8.  Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei.

Authors:  William Byne; Stella Dracheva; Benjamin Chin; James M Schmeidler; Kenneth L Davis; Vahram Haroutunian
Journal:  Schizophr Res       Date:  2007-10-29       Impact factor: 4.939

9.  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Authors:  Alice Egerton; Lee Reid; Sandie McGregor; Susan M Cochran; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2008-04-23       Impact factor: 4.530

Review 10.  Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices.

Authors:  George K Aghajanian
Journal:  Psychopharmacology (Berl)       Date:  2009-02-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.